Company

ChromaCon AG is a Swiss biopharmaceutical tool company providing enabling purification technologies, equipment and services.

Its proprietary ContiChrom technology (using the MCSGP principle) is based on continuous chromatography, a powerful tool for the economic purification of components from complex mixtures, enabling the development of previously not accessible novel biological medicines and life cycle products with improved characteristics.

Its unique technology with broad applicability has strong IP protection, covering prospective exclusivity and freedom to operate. The technology has been validated by executing a number of customer projects and sales of ContiChrom equipment to biopharma customers.